sirtuin-2 inhibitors (Northwestern University/Massachusetts General Hospital/BioPontis Alliance)

N/A

Report date: 2025/03/20 09:28:01
NME

Base Information

Drug Namesirtuin-2 inhibitors (Northwestern University/Massachusetts General Hospital/BioPontis Alliance)
Drug Alias Namesirtuin-2 inhibitors (Northwestern University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesThe General Hospital Corporation D/B/A Massachusetts General HospitalBioPontis Alliance LlcNorthwestern University
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A